Cargando…
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631644/ https://www.ncbi.nlm.nih.gov/pubmed/35834728 http://dx.doi.org/10.1182/bloodadvances.2022008093 |
| _version_ | 1784823858695503872 |
|---|---|
| author | Hsieh, Emily M. Myers, Regina M. Yates, Bonnie Annesley, Colleen John, Samuel Taraseviciute, Agne Steinberg, Seth M. Sheppard, Jennifer Chung, Perry Chen, Lee Lee, Daniel W. DiNofia, Amanda Grupp, Stephan A. Verneris, Michael R. Laetsch, Theodore W. Bhojwani, Deepa Brown, Patrick A. Pulsipher, Michael A. Rheingold, Susan R. Gardner, Rebecca A. Gore, Lia Shah, Nirali N. Lamble, Adam J. |
| author_facet | Hsieh, Emily M. Myers, Regina M. Yates, Bonnie Annesley, Colleen John, Samuel Taraseviciute, Agne Steinberg, Seth M. Sheppard, Jennifer Chung, Perry Chen, Lee Lee, Daniel W. DiNofia, Amanda Grupp, Stephan A. Verneris, Michael R. Laetsch, Theodore W. Bhojwani, Deepa Brown, Patrick A. Pulsipher, Michael A. Rheingold, Susan R. Gardner, Rebecca A. Gore, Lia Shah, Nirali N. Lamble, Adam J. |
| author_sort | Hsieh, Emily M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9631644 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96316442022-11-04 Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy Hsieh, Emily M. Myers, Regina M. Yates, Bonnie Annesley, Colleen John, Samuel Taraseviciute, Agne Steinberg, Seth M. Sheppard, Jennifer Chung, Perry Chen, Lee Lee, Daniel W. DiNofia, Amanda Grupp, Stephan A. Verneris, Michael R. Laetsch, Theodore W. Bhojwani, Deepa Brown, Patrick A. Pulsipher, Michael A. Rheingold, Susan R. Gardner, Rebecca A. Gore, Lia Shah, Nirali N. Lamble, Adam J. Blood Adv Research Letter American Society of Hematology 2022-09-07 /pmc/articles/PMC9631644/ /pubmed/35834728 http://dx.doi.org/10.1182/bloodadvances.2022008093 Text en Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Hsieh, Emily M. Myers, Regina M. Yates, Bonnie Annesley, Colleen John, Samuel Taraseviciute, Agne Steinberg, Seth M. Sheppard, Jennifer Chung, Perry Chen, Lee Lee, Daniel W. DiNofia, Amanda Grupp, Stephan A. Verneris, Michael R. Laetsch, Theodore W. Bhojwani, Deepa Brown, Patrick A. Pulsipher, Michael A. Rheingold, Susan R. Gardner, Rebecca A. Gore, Lia Shah, Nirali N. Lamble, Adam J. Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy |
| title | Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy |
| title_full | Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy |
| title_fullStr | Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy |
| title_full_unstemmed | Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy |
| title_short | Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy |
| title_sort | low rate of subsequent malignant neoplasms after cd19 car t-cell therapy |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631644/ https://www.ncbi.nlm.nih.gov/pubmed/35834728 http://dx.doi.org/10.1182/bloodadvances.2022008093 |
| work_keys_str_mv | AT hsiehemilym lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT myersreginam lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT yatesbonnie lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT annesleycolleen lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT johnsamuel lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT taraseviciuteagne lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT steinbergsethm lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT sheppardjennifer lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT chungperry lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT chenlee lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT leedanielw lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT dinofiaamanda lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT gruppstephana lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT vernerismichaelr lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT laetschtheodorew lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT bhojwanideepa lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT brownpatricka lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT pulsiphermichaela lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT rheingoldsusanr lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT gardnerrebeccaa lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT gorelia lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT shahniralin lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy AT lambleadamj lowrateofsubsequentmalignantneoplasmsaftercd19cartcelltherapy |